WallStreetZenWallStreetZen

NASDAQ: PMVP
Pmv Pharmaceuticals Inc Stock Ownership - Who owns Pmv Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pmv Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Henry MacKPresident and CEO2025-10-27220,643$1.37
$302.28kBuy
Orbimed Advisors LLC10% Owner2025-10-231,000,000$1.52
$1.52MSell
Orbimed Advisors LLC10% Owner2025-09-10500,000$1.80
$900.00kSell
Robert TicktinGeneral Counsel COO2025-07-0123,151$1.07
$24.66kSell
Deepika JalotaChief Development Officer2025-07-0133,065$1.07
$35.21kSell
David Henry MacKPresident and CEO2025-07-0158,411$1.07
$62.21kSell
Michael CarulliChief Financial Officer2025-07-0128,249$1.07
$30.09kSell
David Henry MacKPresident and CEO2025-01-0317,709$0.53
$9.39kBuy

1 of 1

PMVP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMVP insiders and whales buy or sell their stock.

PMVP Shareholders

What type of owners hold Pmv Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arnold L. Oronsky12.16%6,469,911$8.02MInsider
Orbimed Advisors LLC11.23%5,975,291$7.41MInstitution
Bml Capital Management LLC9.95%5,292,000$6.56MInstitution
Orbimed Advisors LLC9.56%5,089,330$6.31MInsider
Tang Capital Management LLC8.99%4,785,201$5.93MInstitution
Interwest Partners X LP8.46%4,502,480$5.58MInsider
Arrowmark Colorado Holdings LLC6.20%3,301,341$4.09MInstitution
Sio Capital Management LLC4.95%2,636,548$3.27MInstitution
Euclidean Capital LLC4.94%2,627,643$3.26MInstitution
V. Oncology Scs Sicavsif Nextech4.75%2,528,290$3.14MInsider

1 of 3

PMVP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMVP58.97%41.03%Net SellingNet Selling
PYXS43.09%37.50%
ANL0.01%0.00%
CYPH20.35%79.65%Net SellingNet Selling
MNOV10.46%89.10%
View Top Biotech Stocks

Pmv Pharmaceuticals Stock Ownership FAQ

Who owns Pmv Pharmaceuticals?

Pmv Pharmaceuticals (NASDAQ: PMVP) is owned by 70.46% institutional shareholders, 49.03% Pmv Pharmaceuticals insiders, and 0.00% retail investors. Arnold L. Oronsky is the largest individual Pmv Pharmaceuticals shareholder, owning 6.47M shares representing 12.16% of the company. Arnold L. Oronsky's Pmv Pharmaceuticals shares are currently valued at $7.89M.

If you're new to stock investing, here's how to buy Pmv Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.